Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner

被引:36
|
作者
Promadej, N
Costello, C
Wernett, MM
Kulkarni, PS
Robison, VA
Nelson, KE
Hodge, TW
Suriyanon, V
Duerr, A
McNicholl, JM
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA
[2] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Res Inst Hlth Sci, Chiang Mai, Thailand
来源
JOURNAL OF INFECTIOUS DISEASES | 2003年 / 187卷 / 07期
关键词
D O I
10.1086/368127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eighteen highly exposed but persistently seronegative (HEPS) women (HW) and their human immunodeficiency virus (HIV) type 1-seropositive male partners were studied for HIV-specific T cells and other host factors. Circulating HIV-specific T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vaccinia virus vectors expressing HIV proteins. Nine (50%) of the HW and all HIV-seropositive persons had HIV-specific T cell responses. Only 2 (22%) of the HEPS responders recognized Env, compared with 94% of HIV-seropositive persons. A high percentage (75%) of the HW with HIV-specific T cell responses reported recent HIV exposure. Remarkably, however, long-lived HIV-specific T cells were detected in 2 HW who had an extended period (>3.9 years) of no HIV exposure. These findings have important implications for HIV vaccine design.
引用
收藏
页码:1053 / 1063
页数:11
相关论文
共 50 条
  • [41] Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis
    Goncalves, Lucio de Souza
    Soares Ferreira, Sonia Maria
    Souza, Celso Oliveira
    Souto, Renata
    Colombo, Ana Paula
    JOURNAL OF PERIODONTOLOGY, 2007, 78 (01) : 87 - 96
  • [42] Human Immunodeficiency Virus (HIV), HIV-Specific Factors, and Myocardial Disease in Women
    Kato, Yoko
    Ambale-Venkatesh, Bharath
    Naveed, Mahim
    Shitole, Sanyog G.
    Peng, Qi
    Levsky, Jeffrey M.
    Haramati, Linda B.
    Ordovas, Karen
    Noworolski, Susan M.
    Lee, Yoo Jin
    Kim, Ryung S.
    Lazar, Jason M.
    Anastos, Kathryn
    Tien, Phyllis C.
    Kaplan, Robert C.
    Lima, Joao A. C.
    Kizer, Jorge R.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (02) : 451 - 461
  • [43] Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women
    Cohn, MA
    Frankel, SS
    Rugpao, S
    Young, MA
    Willett, G
    Tovanabutra, S
    Khamboonruang, C
    VanCott, T
    Bhoopat, L
    Barrick, S
    Fox, C
    Quinn, TC
    Vahey, M
    Nelson, KE
    Weissman, D
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (04): : 410 - 417
  • [44] Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-Seronegative Ugandan volunteers: Results of the HIV Network for Prevention Trials 007 vaccine study
    Cao, H
    Kaleebu, P
    Hom, D
    Flores, J
    Agrawal, D
    Jones, N
    Serwanga, J
    Okello, M
    Walker, C
    Sheppard, H
    El-Habib, R
    Klein, M
    Mbidde, E
    Mugyenyi, P
    Walker, B
    Ellner, J
    Mugerwa, R
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (06): : 887 - 895
  • [45] Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants
    Holditch, Sara J.
    Eriksson, Emily M.
    Tarosso, Leandro F.
    Kuebler, Peter J.
    Kallas, Esper G.
    Nielsen, Erik K.
    Wiznia, Andrew A.
    Rosenberg, Michael G.
    Nixon, Douglas F.
    FRONTIERS IN IMMUNOLOGY, 2012, 2
  • [46] Human immunodeficiency virus (HIV) type 1-specific B cell response in seronegative subjects at risk for HIV exposure
    Angarano, G
    Fiore, JR
    DiStefano, M
    Monno, L
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02): : 447 - 448
  • [47] Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients
    Schenal, M
    Lo Caputo, S
    Fasano, F
    Vichi, F
    Saresella, M
    Pierotti, P
    Villa, ML
    Mazzotta, F
    Trabattoni, D
    Clerici, M
    AIDS, 2005, 19 (07) : 653 - 661
  • [48] Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children
    Punpanich, Warunee
    Groome, Michelle
    Muhe, Lulu
    Qazi, Shamim A.
    Madhi, Shabir A.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (02): : 109 - 119
  • [49] Safety of autologous, ex vivo expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients
    Lieberman, J
    Skolnik, PR
    Parkerson, GR
    Fabry, JA
    Landry, B
    Bethel, J
    Kagan, J
    Atkins, MB
    Gradon, J
    Stein, D
    ViraniKetter, N
    Banach, M
    Scott, M
    Meyers, J
    Lee, E
    Standiford, H
    Fong, DM
    Wang, A
    Beyer, D
    BLOOD, 1997, 90 (06) : 2196 - 2206
  • [50] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) NEF-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN NONINFECTED HETEROSEXUAL CONTACT OF HIV-INFECTED PATIENTS
    LANGLADEDEMOYEN, P
    NGOGIANGHUONG, N
    FERCHAL, F
    OKSENHENDLER, E
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03): : 1293 - 1297